Singapore markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
13.16+0.05 (+0.34%)
As of 12:28PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 41.35B
Enterprise value 68.73B
Trailing P/E 30.86
Forward P/E 10.53
PEG Ratio (5 yr expected) 0.58
Price/sales (ttm)1.71
Price/book (mrq)0.95
Enterprise value/revenue 0.02
Enterprise value/EBITDA 0.07

Trading information

Stock price history

Beta (5Y monthly) 0.75
52-week change 3-7.93%
S&P500 52-week change 3-14.73%
52-week high 315.36
52-week low 312.75
50-day moving average 313.67
200-day moving average 314.24

Share statistics

Avg vol (3-month) 32.58M
Avg vol (10-day) 33.34M
Shares outstanding 53.09B
Implied shares outstanding 6N/A
Float 82.99B
% held by insiders 10.01%
% held by institutions 11.88%
Shares short (14 Sept 2022) 43.44M
Short ratio (14 Sept 2022) 41.6
Short % of float (14 Sept 2022) 4N/A
Short % of shares outstanding (14 Sept 2022) 40.11%
Shares short (prior month 14 Aug 2022) 43.2M

Dividends & splits

Forward annual dividend rate 40.73
Forward annual dividend yield 45.40%
Trailing annual dividend rate 3180.00
Trailing annual dividend yield 31,371.95%
5-year average dividend yield 44.54
Payout ratio 4134.49%
Dividend date 314 Dec 2009
Ex-dividend date 429 Mar 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 30 Mar 2022
Most-recent quarter (mrq)29 Jun 2022


Profit margin 5.49%
Operating margin (ttm)13.96%

Management effectiveness

Return on assets (ttm)2.35%
Return on equity (ttm)3.42%

Income statement

Revenue (ttm)3.59T
Revenue per share (ttm)1,152.26
Quarterly revenue growth (yoy)2.40%
Gross profit (ttm)2.44T
Net income avi to common (ttm)197.39B
Diluted EPS (ttm)0.44
Quarterly earnings growth (yoy)-23.70%

Balance sheet

Total cash (mrq)645.99B
Total cash per share (mrq)208.91
Total debt (mrq)5.11T
Total debt/equity (mrq)80.91
Current ratio (mrq)1.18
Book value per share (mrq)2,042.83

Cash flow statement

Operating cash flow (ttm)1.04T
Levered free cash flow (ttm)771.04B